BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 24071482)

  • 1. Microbiota regulation of inflammatory bowel disease and colorectal cancer.
    Liu Z; Cao AT; Cong Y
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):543-52. PubMed ID: 24071482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases.
    Silva MJ; Carneiro MB; dos Anjos Pultz B; Pereira Silva D; Lopes ME; dos Santos LM
    J Immunol Res; 2015; 2015():321241. PubMed ID: 25759839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucins in inflammatory bowel diseases and colorectal cancer.
    Sheng YH; Hasnain SZ; Florin TH; McGuckin MA
    J Gastroenterol Hepatol; 2012 Jan; 27(1):28-38. PubMed ID: 21913981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
    Jackson DN; Theiss AL
    Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perturbations of mucosal homeostasis through interactions of intestinal microbes with myeloid cells.
    Schey R; Danzer C; Mattner J
    Immunobiology; 2015 Feb; 220(2):227-35. PubMed ID: 25466587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal microbiota in inflammatory bowel disease: friend of foe?
    Fava F; Danese S
    World J Gastroenterol; 2011 Feb; 17(5):557-66. PubMed ID: 21350704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
    Kang M; Martin A
    Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between the intestinal microbiota and the innate immune system in intestinal homeostasis and inflammatory bowel disease.
    Dupaul-Chicoine J; Dagenais M; Saleh M
    Inflamm Bowel Dis; 2013 Sep; 19(10):2227-37. PubMed ID: 23669404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of intestinal homeostasis through crosstalk between natural killer T cells and the intestinal microbiota.
    Dowds CM; Blumberg RS; Zeissig S
    Clin Immunol; 2015 Aug; 159(2):128-33. PubMed ID: 25988859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the complex interactions between microbiota, host epithelial and immune cells in inflammatory bowel disease.
    Hirata Y; Ihara S; Koike K
    Pharmacol Res; 2016 Nov; 113(Pt A):574-584. PubMed ID: 27702681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota-antibody interactions that regulate gut homeostasis.
    Weis AM; Round JL
    Cell Host Microbe; 2021 Mar; 29(3):334-346. PubMed ID: 33705705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARD9 Signaling in Intestinal Immune Homeostasis and Oncogenesis.
    Hartjes L; Ruland J
    Front Immunol; 2019; 10():419. PubMed ID: 30906296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of probiotics and gut microbiota on Th17 cells.
    Tanabe S
    Int Rev Immunol; 2013; 32(5-6):511-25. PubMed ID: 24094077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crosstalk between gut bacteria and host immunity in intestinal inflammation.
    Yang Q; Wang Y; Jia A; Wang Y; Bi Y; Liu G
    J Cell Physiol; 2021 Apr; 236(4):2239-2254. PubMed ID: 32853458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota Regulation of T Cells During Inflammation and Autoimmunity.
    Brown EM; Kenny DJ; Xavier RJ
    Annu Rev Immunol; 2019 Apr; 37():599-624. PubMed ID: 31026411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Dietary Sphingolipids on Intestinal Microbiota and Gastrointestinal Immune Homeostasis.
    Rohrhofer J; Zwirzitz B; Selberherr E; Untersmayr E
    Front Immunol; 2021; 12():635704. PubMed ID: 34054805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota regulation of inflammatory bowel disease.
    Evans-Marin HL; Cong Y
    Inflamm Allergy Drug Targets; 2014 Feb; 13(1):65-73. PubMed ID: 24438006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
    Yu Y; Yang W; Li Y; Cong Y
    Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.